These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 11055609)

  • 1. Bacteriologic outcome of children with cefotaxime- or ceftriaxone-susceptible and -nonsusceptible Streptococcus pneumoniae meningitis.
    Olivier C; Cohen R; Begué P; Floret D
    Pediatr Infect Dis J; 2000 Oct; 19(10):1015-7. PubMed ID: 11055609
    [No Abstract]   [Full Text] [Related]  

  • 2. Antibiotic therapy and acute outcome of meningitis due to Streptococcus pneumoniae considered intermediately susceptible to broad-spectrum cephalosporins.
    Tan TQ; Schutze GE; Mason EO; Kaplan SL
    Antimicrob Agents Chemother; 1994 May; 38(5):918-23. PubMed ID: 8067771
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Three-year multicenter surveillance of pneumococcal meningitis in children: clinical characteristics, and outcome related to penicillin susceptibility and dexamethasone use.
    Arditi M; Mason EO; Bradley JS; Tan TQ; Barson WJ; Schutze GE; Wald ER; Givner LB; Kim KS; Yogev R; Kaplan SL
    Pediatrics; 1998 Nov; 102(5):1087-97. PubMed ID: 9794939
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Time-kill studies of antimicrobial combinations including cefotaxime, ceftriaxone, vancomycin and meropenem against cephalosporin-resistant Streptococcus pneumoniae.
    Kim BN; Woo JH; Kim YS; Ryu J; Kim MN; Pai CH
    Chemotherapy; 2000; 46(5):303-8. PubMed ID: 10965094
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cefotaxime failure in pneumococcal meningitis caused by a susceptible isolate.
    Flórez C; Silva G; Martín E
    Pediatr Infect Dis J; 1996 Aug; 15(8):723-4. PubMed ID: 8858688
    [No Abstract]   [Full Text] [Related]  

  • 6. [Therapeutic failure with high-dose cefotaxime in pneumococcal meningitis].
    Michaus ML; Pérez-Díaz L; de Pablos M; Lezaun MJ; López-Bayón J
    Enferm Infecc Microbiol Clin; 1997 May; 15(5):276-7. PubMed ID: 9376392
    [No Abstract]   [Full Text] [Related]  

  • 7. Clinical outcomes of meningitis caused by Streptococcus pneumoniae in the era of antibiotic resistance.
    Fiore AE; Moroney JF; Farley MM; Harrison LH; Patterson JE; Jorgensen JH; Cetron M; Kolczak MS; Breiman RF; Schuchat A
    Clin Infect Dis; 2000 Jan; 30(1):71-7. PubMed ID: 10619736
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Screening for cephalosporin-resistant Streptococcus pneumoniae with the Kirby-Bauer disk susceptibility test.
    Friedland IR; Shelton S; McCracken GH
    J Clin Microbiol; 1993 Jun; 31(6):1619-21. PubMed ID: 8315005
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro killing of penicillin-susceptible, -intermediate, and -resistant strains of Streptococcus pneumoniae by cefotaxime, ceftriaxone, and ceftizoxime: a comparison of bactericidal and inhibitory activity with achievable CSF levels.
    Stratton CW; Aldridge KE; Gelfand MS
    Diagn Microbiol Infect Dis; 1995; 22(1-2):35-42. PubMed ID: 7587048
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Streptococcus pneumoniae susceptible to benzylpenicillin but with reduced susceptibility to both cefotaxime and ceftriaxone.
    Bell SM; Gatus BJ; Pham JN
    Med J Aust; 1996 Feb; 164(3):188. PubMed ID: 8628145
    [No Abstract]   [Full Text] [Related]  

  • 11. Relationship of MICs to efficacy of cefotaxime in treatment of Streptococcus pneumoniae infections.
    Jacobs RF; Kaplan SL; Schutze GE; Dajani AS; Leggiadro RJ; Rim CS; Puri SK
    Antimicrob Agents Chemother; 1996 Apr; 40(4):895-8. PubMed ID: 8849247
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Outcome of invasive infections outside the central nervous system caused by Streptococcus pneumoniae isolates nonsusceptible to ceftriazone in children treated with beta-lactam antibiotics.
    Kaplan SL; Mason EO; Barson WJ; Tan TQ; Schutze GE; Bradley JS; Givner LB; Kim KS; Yogev R; Wald ER
    Pediatr Infect Dis J; 2001 Apr; 20(4):392-6. PubMed ID: 11332663
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Penicillin and ceftriaxone susceptibility of Streptococcus pneumoniae isolated from cerebrospinal fluid of children with meningitis hospitalized in a tertiary hospital in Israel.
    Waisbourd-Zinman O; Bilavsky E; Tirosh N; Samra Z; Amir J
    Isr Med Assoc J; 2010 Apr; 12(4):225-8. PubMed ID: 20803882
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of ceftriaxone, vancomycin and rifampicin alone and combined in an experimental model of meningitis caused by highly cephalosporin-resistant Streptococcus pneumoniae ATCC 51916.
    Ribes S; Taberner F; Domenech A; Cabellos C; Tubau F; Liñares J; Fernández Viladrich P; Gudiol F
    J Antimicrob Chemother; 2005 Nov; 56(5):979-82. PubMed ID: 16174686
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibiotic susceptibility and serotype distribution of 240 Streptococcus pneumoniae causing meningitis in Belgium 1997-2000.
    Verhaegen J; Vandecasteele SJ; Vandeven J; Verbiest N; Lagrou K; Peetermans WE
    Acta Clin Belg; 2003; 58(1):19-26. PubMed ID: 12723258
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of combined ceftriaxone and dexamethasone therapy in experimental cephalosporin-resistant pneumococcal meningitis.
    Cabellos C; Martínez-Lacasa J; Tubau F; Fernández A; Viladrich PF; Liñares J; Gudiol F
    J Antimicrob Chemother; 2000 Mar; 45(3):315-20. PubMed ID: 10702550
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Management of pneumococcal meningitis.
    Kaplan SL
    Pediatr Infect Dis J; 2002 Jun; 21(6):589-91; discussion 613-4. PubMed ID: 12182395
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Penicillin-resistant Streptococcus pneumoniae.
    Hedge DD
    S D J Med; 1996 Nov; 49(11):423-4. PubMed ID: 8973136
    [No Abstract]   [Full Text] [Related]  

  • 19. Dilemmas in diagnosis and management of cephalosporin-resistant Streptococcus pneumoniae meningitis.
    Friedland IR; Shelton S; Paris M; Rinderknecht S; Ehrett S; Krisher K; McCracken GH
    Pediatr Infect Dis J; 1993 Mar; 12(3):196-200. PubMed ID: 8451095
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical implications of penicillin and ceftriaxone resistance among children with pneumococcal bacteremia.
    Silverstein M; Bachur R; Harper MB
    Pediatr Infect Dis J; 1999 Jan; 18(1):35-41. PubMed ID: 9951978
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.